Literature DB >> 18625517

Salvianolic acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor alpha2beta1.

Ya Ping Wu1, Xiao Min Zhao, Shao Dong Pan, De An Guo, Ran Wei, Ji Ju Han, Mie Kainoh, Zuo Li Xia, Philip G de Groot, Ton Lisman.   

Abstract

Salvianolic acid B (SAB) is a component of Danshen, a herb widely used in Chinese medicine, and was previously shown to exert a number of biological activities including inhibition of platelet function, but the exact mechanisms involved are unclear. SAB dose-dependently inhibited platelet deposition from flowing, anticoagulated whole blood to immobilized collagen at both venous and arterial shear rate, whereas platelet deposition to immobilized fibrinogen was not affected. The inhibitory effect of SAB on platelet adhesion to collagen was independent of alphaIIbbeta3, since SAB still inhibited platelet deposition in the presence of a alphaIIbbeta3-blocking peptide. SAB inhibited static platelet adhesion to a synthetic peptide specific for the collagen receptor alpha2beta1, whereas platelet adhesion to a glycoprotein VI-specific peptide was not affected. SAB inhibited binding of an antibody against alpha2beta1 to platelets as studied by flow cytometry, and inhibited the interaction of soluble alpha2beta1 to immobilized collagen in a solid phase binding assay. These combined results indicate that SAB inhibits platelet adhesion to immobilized collagen by interfering with the collagen receptor alpha2beta1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625517     DOI: 10.1016/j.thromres.2008.05.020

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  12 in total

1.  Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B.

Authors:  Chao Ma; Yan Yao; Qing-Xi Yue; Xin-Wen Zhou; Peng-Yuan Yang; Wan-Ying Wu; Shu-Hong Guan; Bao-Hong Jiang; Min Yang; Xuan Liu; De-An Guo
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

Review 2.  Polyphenols for the Treatment of Ischemic Stroke: New Applications and Insights.

Authors:  Shuhan Liu; Feng Lin; Jian Wang; Xiaoqiang Pan; Liguang Sun; Wei Wu
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

3.  An Integrated Strategy to Identify and Quantify the Quality Markers of Xinkeshu Tablets Based on Spectrum-Effect Relationship, Network Pharmacology, Plasma Pharmacochemistry, and Pharmacodynamics of Zebrafish.

Authors:  Yongheng Wei; Lei Nie; Lele Gao; Liang Zhong; Zhongyu Sun; Xiangchun Yang; Jianan Yue; Yingzi Zeng; Lian Li; Jing Sun; Hengchang Zang
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

4.  Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction.

Authors:  Tsai-Hui Lin; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2010-06-21       Impact factor: 5.455

Review 5.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

6.  Effects of Shenlian extract on experimental atherosclerosis in ApoE-deficient mice based on ultrasound biomicroscopy.

Authors:  Yan Guo; Xu-Cen Liu; Ya-Jie Wang; Qi Li; Qing Yang; Xiao-Gang Weng; Ying Chen; Wei-Yan Cai; Xiao-Xi Kan; Xi Chen; He-Fei Huang; Xiao-Xin Zhu; Yu-Jie Li
Journal:  BMC Complement Altern Med       Date:  2016-11-15       Impact factor: 3.659

7.  A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.

Authors:  Jiahui Yu; Wen Zhang; Yiqian Zhang; Yadong Wang; Boli Zhang; Guanwei Fan; Yan Zhu
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

8.  Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen (Salvia miltiorrhiza).

Authors:  Jia Zou; Yang Chen; Maggie Pui Man Hoi; Jun Li; Tao Wang; Ying Zhang; Yu Feng; Jianli Gao; Simon Ming Yuen Lee; Guozhen Cui
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-24       Impact factor: 2.629

9.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

10.  Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.

Authors:  Yu Lu; Quan Li; Yu-Ying Liu; Kai Sun; Jing-Yu Fan; Chuan-She Wang; Jing-Yan Han
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.